Início › Melanoma › Ohio › Cleveland
Ensaios clínicos de Melanoma em Cleveland, OH
13 estudos para Melanoma estão buscando participantes em locais em Cleveland e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RecrutandoFase 3
- Seidman Cancer Center, Cleveland
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
RecrutandoFase 3
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · a 10 mi de distância
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RecrutandoFase 2
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · a 10 mi de distância
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RecrutandoEstudo observacional
- Cleveland Clinic, Cleveland
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
RecrutandoFase 1
- Cleveland Clinic, Cleveland
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
RecrutandoFase 1/2
- Cleveland Clinic Taussig Cancer Center, Cleveland
Project: Every Child for Younger Patients With Cancer
RecrutandoEstudo observacional
- Rainbow Babies and Childrens Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
Neoadjuvant Darovasertib in Primary Uveal Melanoma
RecrutandoFase 3
- Cole Eye Institute-9500 Euclid Ave, Cleveland
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
RecrutandoFase 1/2
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Mayfield Heights · a 12 mi de distância
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- Cleveland Clinic, Cleveland
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Recrutando
- University Hospitals Cleveland Medical Centre, Cleveland
- University Hospitals Chagrin Highlands Medical Centre, Orange · a 12 mi de distância
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
RecrutandoFase 1/2
- Cleveland Clinic, Cleveland
Ensaios de Melanoma em outras cidades
- Houston, TX59 estudos
- New York City, NY38 estudos
- Los Angeles, CA34 estudos
- Nashville, TN33 estudos
- Pittsburgh, PA31 estudos
- Boston, MA26 estudos
- Philadelphia, PA23 estudos
- San Francisco, CA22 estudos
- Durham, NC21 estudos
- Atlanta, GA21 estudos
- St. Louis, MO21 estudos
- Salt Lake City, UT21 estudos
Outros estudos em Cleveland
- Câncer de Pulmão de Não Pequenas Células43 estudos
- Câncer (todos os tipos)36 estudos
- Câncer de Mama35 estudos
- Câncer de Próstata34 estudos
- Insuficiência Cardíaca33 estudos
- Câncer Metastático30 estudos
- Câncer de Ovário30 estudos
- Câncer de Pulmão26 estudos
- Câncer Colorretal24 estudos
- Doença Cardiovascular22 estudos
- Câncer Endometrial20 estudos
- Leucemia Mieloide Aguda20 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.